Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-107
Closed -$8.01K 1103
2022
Q4
$8.01K Buy
+107
New +$7.62K ﹤0.01% 667
2022
Q3
Sell
-107
Closed -$7K 574
2022
Q2
$7K Buy
+107
New +$7.94K ﹤0.01% 752

Other funds holding HOLX

Concord Wealth Partners's HOLX Position: Q1 2023 in Review

Concord Wealth Partners sold out of Hologic (HOLX) in Q1 2023, closing a stake of 107 shares — an estimated $8.01K sold.

Concord Wealth Partners first reported a position in HOLX in Q2 2022 and held it in 2 quarters. The position peaked at $8.01K in Q4 2022. 708 funds tracked by Wall St. Rank hold HOLX as of Q1 2023.

  • Concord Wealth Partners reported no remaining Hologic position as of Q1 2023 after selling out during the quarter.
  • Concord Wealth Partners sold 107 Hologic shares in Q1 2023, an estimated $8.01K.
  • Concord Wealth Partners first reported a position in Hologic in Q2 2022 and held it in 2 quarters.
  • Concord Wealth Partners's Hologic position peaked at $8.01K in Q4 2022.
  • 708 funds tracked by Wall St. Rank held Hologic as of Q1 2023.

Based on Concord Wealth Partners's 13F filing for Q1 2023, filed 26 Apr 2023.